2m 2m 2m 2m 2m 2m 2m
RECURSN PHARMA-A (RXRX)
NASDAQ
$3.50-$0.005 (-0.14%)
Price as of Aug 21, 2026 7:59 PM EDT- $1.9BMarket Cap
- -29.15%1-Year Change
- BiotechnologyIndustry
RECURSN PHARMA-A (RXRX)
$3.50-$0.005 (-0.14%)
Earnings Score
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 5.61% | ||
12-Month Momentum | -37.03% | ||
3-Month Risk Adjusted Momentum | 17.91% | ||
12-Month Risk Adjusted Momentum | -54.52% |
True Yield
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.01% | ||
Net Debt Paydown Yield | 0.11% |
Financial Health Score
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |